Real-time enrollment status for this waldenstrom macroglobulinemia clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 6:52 PM UTC
| NCT Number | NCT06561347 |
| Recruiting Status | Recruiting |
| Condition | Waldenstrom Macroglobulinemia |
| Phase | PHASE2 |
| Target Enrollment | 56 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Massachusetts General Hospital |
| Last Updated on CT.gov | June 8, 2026 (Jun 8, 2026) |
As of July 18, 2026: Clinical trial NCT06561347 is currently recruiting participants. This phase2 study for waldenstrom macroglobulinemia is actively seeking new participants at 5 locations across the United States. The study is sponsored by Massachusetts General Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06561347 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06561347 was last updated Jun 8, 2026 (June 8, 2026). HelloStudys verifies this status automatically.